Previous studies from our team [20] showed that MEF2C is expressed in perivascular BC cells, in the early stages of metastatic development, as well as in well-established metastases, in a mouse model of BC brain metastases (BCBM) formation. This evidence concerns the gene MEF2C and breast cancer.